{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:57:21Z","timestamp":1771487841262,"version":"3.50.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4529,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.fertnstert.2008.09.086","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T04:15:04Z","timestamp":1231992904000},"page":"239-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model"],"prefix":"10.1016","volume":"93","author":[{"given":"Memy H.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salama A.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam M.M.","family":"Arafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid M.A.","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2008.09.086_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0039-128X(00)00171-9","article-title":"Effects of progesterone on uterine leiomyoma growth and apoptosis","volume":"65","author":"Maruo","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/107155760000700410","article-title":"Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma","volume":"7","author":"Walker","year":"2000","journal-title":"J Soc Gynecol Invest"},{"issue":"9252","key":"10.1016\/j.fertnstert.2008.09.086_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib4","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/oxfordjournals.humrep.a135748","article-title":"Effect of uterine leiomyomata on the results of in-vitro fertilization treatment","volume":"10","author":"Farhi","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib5","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0015-0282(98)00265-9","article-title":"Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment","volume":"70","author":"Eldar-Geva","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0015-0282(00)01714-3","article-title":"Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization\u2013embryo transfer cycle outcome","volume":"75","author":"Surrey","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib7","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/humrep\/16.11.2411","article-title":"A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception","volume":"16","author":"Hart","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9378(95)90077-2","article-title":"Progesterone: a critical role in the pathogenesis of uterine myomas","volume":"172","author":"Rein","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0015-0282(16)49332-5","article-title":"Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri","volume":"45","author":"Coddington","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0002-9378(89)80046-8","article-title":"Mitotic activity in uterine leiomyomas during the menstrual cycle","volume":"160","author":"Kawaguchi","year":"1989","journal-title":"Am J Obstetric Gynecology"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/humupd\/2.4.295","article-title":"Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era","volume":"4","author":"Stewart","year":"1996","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1071-55760300004-2","article-title":"Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy","volume":"10","author":"Chegini","year":"2003","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(02)03154-0","article-title":"Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata","volume":"78","author":"Sozen","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib14","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ajog.2004.04.022","article-title":"Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice","volume":"191","author":"Al-Hendy","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00001648-199607000-00018","article-title":"Reproductive factors and risk of uterine fibroids","volume":"7","author":"Parazzini","year":"1996","journal-title":"Epidemiology"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/bmj.293.6543.359","article-title":"Risk factors for uterine fibroids: reduced risk associated with oral contraceptives","volume":"293","author":"Ross","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib17","first-page":"E1112","article-title":"Estrogen receptors (ERalpha\/ERbeta) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma","volume":"276","author":"Benassayag","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1460447","article-title":"Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells","volume":"146","author":"Wang","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.fertnstert.2006.01.052","article-title":"Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans","volume":"86","author":"Al-Hendy","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9378(93)90135-6","article-title":"Progesterone receptor messenger ribonucleic acid and protein are over expressed in human uterine leiomyomas","volume":"169","author":"Brandon","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib21","first-page":"1876","article-title":"Estrogen receptor gene expression in human uterine leiomyomata","volume":"80","author":"Brandon","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib22","first-page":"625","article-title":"Submucous myomas treated with gonadotropin releasing hormone agonist and resulting in vaginal hemorrhage. A case report","volume":"36","author":"Thorp","year":"1991","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib23","first-page":"55","article-title":"Treatment options for uterine fibroids","volume":"17","author":"Vilos","year":"2000","journal-title":"Can J Diag"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib24","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1126\/science.1112063","article-title":"Uterine fibroids: the elephant in the room","volume":"308","author":"Walker","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.fertnstert.2005.09.010","article-title":"Expanding treatment options for women with symptomatic uterine leiomyomas: timely medical breakthroughs","volume":"85","author":"Bachmann","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib26","first-page":"37","article-title":"Clinical Practice Gynecology Committee and Executive Committee and Council. SOGC clinical guidelines","volume":"24","author":"Lefebvre","year":"2002","journal-title":"Hysterectomy. J Obstet Gynecol Can"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib27","first-page":"301","article-title":"Changing trends in treatment of leiomyomata uteri","volume":"5","author":"VeKaut","year":"1993","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/humupd\/dml015","article-title":"Gene therapy and uterine leiomyoma: a review","volume":"16","author":"Al Hendy","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/humrep\/13.4.873","article-title":"Abdominal myomectomy for infertility: a comprehensive review","volume":"13","author":"Vercellini","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1074-3804(98)80034-0","article-title":"Pregnancy outcome after laparoscopic electromyolysis","volume":"5","author":"Vilos","year":"1998","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0015-0282(02)04398-4","article-title":"Serious complications of uterine artery embolization for conservative treatment of fibroids","volume":"79","author":"Payne","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006254-198701000-00001","article-title":"Therapeutic uses of gonadotropin-releasing hormone analogs","volume":"42","author":"Andrei","year":"1987","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib33","first-page":"243","article-title":"Low-dose mifepristone for uterine leiomyomata","volume":"101","author":"Eisinger","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib34","doi-asserted-by":"crossref","first-page":"14026","DOI":"10.1016\/S0021-9258(19)85204-3","article-title":"Powerful dominant negative mutants of the human estrogen receptor","volume":"268","author":"Ince","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/019262301301418900","article-title":"Uterine leiomyomas: mechanisms of tumorigenesis","volume":"29","author":"Houston","year":"2001","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2174\/1566524043359656","article-title":"The Eker rat: establishing a genetic paradigm linking renal cell carcinoma and uterine leiomyoma","volume":"4","author":"Cook","year":"2004","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib37","first-page":"1556","article-title":"Rodent model of reproductive tract leiomyomata. Clinical and pathological features","volume":"146","author":"Everitt","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib38","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1210\/endo.142.9.8372","article-title":"Dominant negative ER induces apoptosis in GH (4) pituitary lactotrope cells and inhibits tumor growth in nude mice","volume":"142","author":"Lee","year":"2001","journal-title":"Endocrinol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1067\/mob.2000.104837","article-title":"Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in\u00a0a novel immunocompetent murine model","volume":"182","author":"Al-Hendy","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib40","series-title":"A text book of pathology, structure and function in disease","author":"Boyd","year":"1979"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib41","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/1522-2586(200012)12:6<826::AID-JMRI5>3.0.CO;2-D","article-title":"Tumor volume measurements of acoustic neuromas with three-dimensional constructive interference in steady state and conventional spin-echo MR imaging","volume":"12","author":"Yamada","year":"2000","journal-title":"Magn Reson Imag"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib42","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/mrm.1078","article-title":"MR microscopy of cobalt-labeled nerve cells and pathways in an invertebrate brain (Sepia officinalis, Cephalopoda)","volume":"45","author":"Quast","year":"2001","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib43","doi-asserted-by":"crossref","first-page":"7675","DOI":"10.1073\/pnas.96.14.7675","article-title":"A visceral pain pathway in the dorsal column of the spinal cord","volume":"96","author":"Willis","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000291870","article-title":"Applying the herpes simplex virus thymidine kinase\/ganciclovir approach to ovarian cancer: an effective in vitro drug-sensitization system","volume":"43","author":"Al-Hendy","year":"1997","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0046-8177(93)90186-K","article-title":"The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogs","volume":"24","author":"Colgan","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000095627","article-title":"Gene therapy of uterine fibroids: adenovirus-mediated herpes simplex virus thymidine kinase\/ganciclovir treatment inhibits growth of human and rat leiomyoma cells","volume":"63","author":"Salama","year":"2007","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib47","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1095\/biolreprod63.5.1322","article-title":"Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat","volume":"63","author":"Burroughs","year":"2000","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib48","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1210\/jc.2007-0823","article-title":"Adenovirus-mediated delivery of a dominant negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression","volume":"92","author":"Hassan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib49","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jsbmb.2007.03.049","article-title":"Progesterone regulates catechol-O-methyl transferase gene expression in breast cancer cells: distinct effect of progesterone receptor isoforms","volume":"107","author":"Salama","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantifications in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib51","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.fertnstert.2006.11.046","article-title":"Gene therapy of endometriosis: adenovirus mediated expression of dominant negative estrogen receptor induces apoptosis in human endometriotic cells","volume":"88","author":"Othman","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib52","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4269\/ajtmh.2006.74.1096","article-title":"Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with pirital virus (Arenaviridae): a rodent model of Lassa fever","volume":"74","author":"Sbrana","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib53","first-page":"3081","article-title":"A cancer gene therapy approach utilizing an antierbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial","volume":"6","author":"Alvarez","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI119149","article-title":"Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries: potential for immunosuppression and vector engineering to overcome barriers of immunity","volume":"99","author":"Schulick","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/ng1293-397","article-title":"Adenovirus-mediated expression of therapeutic plasma levels of human factor-IX in mice","volume":"5","author":"Smith","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib56","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1128\/JVI.73.8.6729-6742.1999","article-title":"Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs","volume":"73","author":"Harvey","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib57","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/edrv-11-3-443","article-title":"Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation","volume":"11","author":"Murphy","year":"1990","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1071-55760300004-2","article-title":"Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy","volume":"10","author":"Chegini","year":"2003","journal-title":"J Soc Gynecol Invest"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib59","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1210\/mend.13.6.0318","article-title":"Adenovirus-mediated delivery of a dominant negative estrogen receptor gene abrogates estrogen-stimulated gene expression and breast cancer cell proliferation","volume":"13","author":"Lazennec","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00428-001-0568-7","article-title":"Cell proliferation and apoptosis in human uterine leiomyomas and myometria","volume":"441","author":"Dixon","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib61","first-page":"3915","article-title":"p53 tumor suppressor protein content in human uterine leiomyomas and its down-regulation by 17B-estradiol","volume":"87","author":"Gao","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib62","first-page":"427","article-title":"Evidence for tight coupling of gonadotropin-releasing hormone receptor to stimulated fas ligand expression in reproductive tract tumors: possible mechanism for hormonal control of apoptotic cell death","volume":"83","author":"Imai","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib63","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00001622-200201000-00015","article-title":"Multiple roles of the tumor suppressor p53","volume":"14","author":"Bargonetti","year":"2002","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib64","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1242\/jcs.00739","article-title":"Apoptosis\u2014the p53 network","volume":"116","author":"Haupt","year":"2003","journal-title":"J\u00a0Cell Sci"},{"issue":"6381","key":"10.1016\/j.fertnstert.2008.09.086_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"Cancer\u2014p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib66","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"issue":"6805","key":"10.1016\/j.fertnstert.2008.09.086_bib67","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","article-title":"CD95's deadly mission in the immune system","volume":"407","author":"Krammer","year":"2000","journal-title":"Nature"},{"issue":"5303","key":"10.1016\/j.fertnstert.2008.09.086_bib68","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.275.5303.1129","article-title":"Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked","volume":"275","author":"Yang","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib69","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.144.2.281","article-title":"Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9\u2013dependent manner","volume":"144","author":"Slee","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib70","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.atherosclerosis.2006.01.004","article-title":"Soluble Fas, a mediator of apoptosis, C-reactive protein, and coronary and extracoronary atherosclerosis\u2014the Rotterdam Coronary Calcification Study","volume":"189","author":"Van der Meer","year":"2006","journal-title":"Atherosclerosis"},{"issue":"5384","key":"10.1016\/j.fertnstert.2008.09.086_bib71","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1126\/science.281.5384.1860","article-title":"Activation of apoptosis signal regulating kinase 1 (Ask1) by the adapter protein Daxx","volume":"281","author":"Chang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib72","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/sj.cdd.4400602","article-title":"Apaf1 and the apoptotic machinery","volume":"6","author":"Cecconi","year":"1999","journal-title":"Cell Death Diff"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib73","first-page":"2883","article-title":"p53AIP1 regulates the mitochondrial apoptotic pathway","volume":"62","author":"Matsuda","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib74","first-page":"2556","article-title":"Bcl-2 blocks p53-dependent apoptosis","volume":"14","author":"Chiou","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0005-2728(98)00108-X","article-title":"Bcl-2 family proteins and mitochondria","volume":"1366","author":"Reed","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib76","first-page":"5542","article-title":"Apoptotic cytosol facilitates Bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2","volume":"59","author":"Nomura","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0960-0760(01)00177-7","article-title":"Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause","volume":"80","author":"Wu","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib78","first-page":"487","article-title":"Maintenance of increased Bcl-2 expression in uterine leiomyomas after GnRH agonist therapy","volume":"44","author":"Khurana","year":"1999","journal-title":"J Reprod Med"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib79","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/molehr\/gah199","article-title":"Growth dynamics of human leiomyoma cells and inhibitory effects of the peroxisome proliferator-activated receptor-gamma ligand, pioglitazone","volume":"11","author":"Loy","year":"2005","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-4827(86)90520-3","article-title":"Expression of proliferating cell nuclear antigen (PCNA)\/cyclin during the cell cycle","volume":"166","author":"Kurki","year":"1986","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib81","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1101\/gad.7.5.812","article-title":"Cyclin D1 is a nuclear protein required for cell cycle progression in G1","volume":"7","author":"Baldin","year":"1993","journal-title":"Genes Dev"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib82","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/bies.10155","article-title":"Defining the actions of transforming growth factor beta in reproduction","volume":"24","author":"Ingman","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib83","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/S0021-9258(17)35666-1","article-title":"Transforming growth-factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular-matrix","volume":"261","author":"Ignotz","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib84","doi-asserted-by":"crossref","first-page":"6443","DOI":"10.1016\/S0021-9258(18)48258-0","article-title":"Regulation of fibronectin and type-I collagen messenger-RNA levels by transforming growth-factor-beta","volume":"262","author":"Ignotz","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/0-306-46817-4_4","article-title":"Targetable gene delivery vectors","volume":"465","author":"Hallenbeck","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib86","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/hum.1997.8.1-37","article-title":"Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration","volume":"8","author":"Worgall","year":"1997","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib87","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/hum.2006.17.230","article-title":"Intracoronary delivery of an adenovirus encoding fibroblast growth factor-4 in myocardial ischemia: effect of serum antibodies and previous exposure to adenovirus","volume":"17","author":"Roth","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib88","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1128\/jvi.69.4.2004-2015.1995","article-title":"Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses","volume":"69","author":"Yang","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib89","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/mthe.2000.0244","article-title":"Host responses and persistence of vector genome following intrabronchial administration of an E1 (\u2212) E3 (\u2212) adenovirus gene transfer vector to normal individuals","volume":"3","author":"Harvey","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib90","first-page":"1170","article-title":"Leiomyomata uteri: hormonal and molecular determinants of growth","volume":"99","author":"Blake","year":"2007","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib91","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2006.10.057","article-title":"Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd)1","volume":"105","author":"Rocconi","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib92","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/sj.gt.3300505","article-title":"Ornithine-delta-aminotransferase expression and ornithine metabolism in cultured epidermal keratinocytes: toward metabolic sink therapy for gyrate atrophy1","volume":"4","author":"Sullivan","year":"1997","journal-title":"Gene Ther"},{"key":"10.1016\/j.fertnstert.2008.09.086_bib93","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/humrep\/dem410","article-title":"Toward gene therapy of uterine fibroids: targeting modified adenovirus to human leiomyoma cells","volume":"23","author":"Hassan","year":"2008","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208041277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208041277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:40:40Z","timestamp":1758008440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028208041277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0015028208041277"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.09.086","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.09.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}